NEWS
See the latest PIR International News, Articles and Network Updates.
Aneesh Karatt Vellatt – BioLeader Interview
CSO & Co-Founder, Maxion Therapeutics (September 2024) Dr Aneesh Karatt Vellatt is Chief Scientific Officer and Co-Founder at Maxion Therapeutics Ltd (Cambridge UK), a company focused on developing antibody treatments for diseases driven by ion channels and GPCRs. Dr Karatt [...]
PIR International Supports Appointment of Non-Executive Chair at Anaveon
PIR International is pleased to announce the appointment of Dieter Weinand as Non-Executive Chair at Anaveon. Anaveon is a global clinical stage biopharmaceutical company that specializes in developing novel treatments for diseases with high unmet needs. The Company was founded [...]
Andreas Katopodis – BioLeader Interview
CEO & Co-Founder, Anaveon (July 2024) Andreas Katopodis is the Co-founder of Anaveon with 26 years’ experience at Novartis and Ciba-Geigy and previously faculty member at the Georgia Institute of Technology. At Anaveon, he has completed multiple funding rounds and [...]
Anja Harmeier – BioLeader Interview
Chief Executive Officer, Rewind Therapeutics (July 2024) Anja Harmeier is an experienced drug developer, scientist and entrepreneur in neuroscience and rare diseases. She brings extensive R&D and operational capabilities complemented by a strong track record in company development and venture [...]